Hybribio and Vision Medicals Sign Strategic Cooperation Agreement on mNGS Infectious Disease Diagnostics
On September 14, Hybribio and Vision Medicals formally signed a strategic cooperation agreement. The two parties will carry out strategic cooperation in the field of metagenomic next-generation sequencing (mNGS) for precision infectious disease diagnostics, promoting the compliant and standardized clinical application of mNGS infectious disease diagnostic services.
Why this event matters
The event has a measured impact on 2 industrys. The strongest current signal is positive for Biotechnology, with intensity 50/100 and 70% confidence over a medium term horizon.
Healthcare · 13.3
Biotechnology
- Direction
- positive
- Intensity
- 50
- Confidence
- 70%
- Horizon
- Medium term
Pharmaceutical R&D Services
- Direction
- positive
- Intensity
- 40
- Confidence
- 65%
- Horizon
- Medium term
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.